Applied DNA Ships LinearDNA™ to Another Development Customer
March 26th, 2020
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
Provisional Patent Application Filed for High Sensitivity COVID-19 Diagnostic Assay
March 24th, 2020
APDN Secures Top-20 Pharmaceutical Manufacturer as Drug Development Customer
March 20th, 2020
Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection
March 19th, 2020
Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models
March 18th, 2020
Applied DNA Sciences (NASDAQ: APDN) Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed
March 2nd, 2020
Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products
February 20th, 2020
Applied DNA Enters Dietary Supplements Market with Multi-year Nutrition21 Contract
February 19th, 2020
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV
February 7th, 2020